{"id":26304,"title":"ASSESSING RTTA ACTIVITY (Support Protocol 6) ","title_html":"<p>ASSESSING RTTA ACTIVITY (Support Protocol 6) <\/p>","image":{"source":"https:\/\/protocols-files.s3.amazonaws.com\/private\/7ef07ff3faeb41d8ea644f433c443c1d6f7d7c3cd480d4aebeeccb93a3f61ccf\/bp4afw26.png?X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAJYFAX46LHRVQMGOA%2F20191211%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20191211T233651Z&X-Amz-SignedHeaders=host&X-Amz-Expires=604800&X-Amz-Signature=bbb76abe6194396280a5e178fa8f7ff13b26b1a8c47f35e5229c5050287f3b72","placeholder":"https:\/\/protocols-files.s3.amazonaws.com\/private\/7ef07ff3faeb41d8ea644f433c443c1d6f7d7c3cd480d4aebeeccb93a3f61ccf\/bp4afw26.png?X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAJYFAX46LHRVQMGOA%2F20191211%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20191211T233651Z&X-Amz-SignedHeaders=host&X-Amz-Expires=604800&X-Amz-Signature=bbb76abe6194396280a5e178fa8f7ff13b26b1a8c47f35e5229c5050287f3b72"},"doi":"dx.doi.org\/10.17504\/protocols.io.5w8g7hw","doi_status":2,"uri":"assessing-rtta-activity-support-protocol-6-5w8g7hw","type_id":1,"published_on":1576695371,"parent_protocols":[],"parent_collections":[],"version_id":0,"created_on":1564174472,"categories":null,"creator":{"name":"Julia Ro\u00dfmanith","affiliation":"Friedrich-Alexander Universit\u00e4t Erlangen-N\u00fcrnberg","affiliations":[{"affiliation":"Friedrich-Alexander Universit\u00e4t Erlangen-N\u00fcrnberg","url":"","is_default":1}],"username":"julia-romanith","link":"https:\/\/doi.org\/10.1002\/cpcb.51","image":{"source":"https:\/\/s3.amazonaws.com\/pr-journal\/bkw6w.jpg","placeholder":"https:\/\/s3.amazonaws.com\/pr-journal\/bkw6w.jpg"},"badges":[{"id":4,"image":{"source":"\/img\/badges\/gold.svg","placeholder":"\/img\/badges\/gold.svg"},"name":"Gold power author!"},{"id":6,"image":{"source":"\/img\/badges\/socialbutterfly.svg","placeholder":"\/img\/badges\/socialbutterfly.svg"},"name":"Social butterfly"}],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"journal":null,"journal_name":null,"journal_link":null,"article_citation":null,"public":1,"has_versions":0,"link":"https:\/\/doi.org\/10.1002\/cpcb.51","total_collections":1,"number_of_steps":9,"authors":[{"name":"Michael S. Fernandopulle","affiliation":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland","affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Ryan Prestil","affiliation":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland","affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Christopher Grunseich","affiliation":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland","affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Chao Wang","affiliation":"Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, California","affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Li Gan","affiliation":"Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, California","affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Michael E. Ward","affiliation":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland","affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false}],"versions":[],"groups":[{"id":1033,"uri":"neurodegeneration-method-development-community1","title":"Neurodegeneration Method Development Community","image":{"source":"https:\/\/s3.amazonaws.com\/pr-journal\/bbxxa.png","placeholder":"https:\/\/s3.amazonaws.com\/pr-journal\/bbxxa.png"},"tech_support":{"email":"ndcn-help@chanzuckerberg.com","phone":"","hide_contact":1,"use_email":0,"url":null},"is_member":0,"request":{"id":1033,"uri":"neurodegeneration-method-development-community1","title":"Neurodegeneration Method Development Community","image":{"source":"https:\/\/s3.amazonaws.com\/pr-journal\/bbxxa.png","placeholder":"https:\/\/s3.amazonaws.com\/pr-journal\/bbxxa.png"},"tech_support":{"email":"ndcn-help@chanzuckerberg.com","phone":"","hide_contact":1,"use_email":0,"url":null},"is_member":0,"description":null,"research_interests":null,"website":null,"location":null,"affiliation":null,"status":{"is_visible":true,"access_level":0},"stats":{"files":[],"total_members":0,"total_followers":0,"total_child_groups":0,"total_parent_groups":0,"has_collaborations":0},"user_status":{"is_member":false,"is_confirmed":true,"is_invited":false,"is_owner":false,"is_admin":false,"is_following":false},"join_link":null,"token":null,"owner":{"name":" ","affiliation":null,"affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"is_protocol_requested":0,"is_group_requested":0,"is_my":false,"is_request":false,"is_confirmed":1,"is_declined":0,"requester":{"name":" ","affiliation":null,"affiliation_url":null,"username":null,"link":null},"protocol":{"id":0,"title":"ASSESSING RTTA ACTIVITY (Support Protocol 6) ","title_html":"ASSESSING RTTA ACTIVITY (Support Protocol 6) ","image":{"source":null,"placeholder":null},"doi":null,"doi_status":0,"uri":"assessing-rtta-activity-support-protocol-6-5w8g7hw","type_id":1,"published_on":null,"stats":{"number_of_views":0,"number_of_steps":0,"number_of_bookmarks":0,"number_of_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"is_voted":0},"parent_protocols":[],"parent_collections":[]},"created_on":1576695336,"resolve_on":0,"resolved_user":{"name":" ","affiliation":null,"affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"shared":false}}],"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"can_be_copied":1,"can_remove_fork":1,"forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":0,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"guid":"8725417DB9DA11E99CA40242AC110005","steps":[{"id":803859,"guid":"3E0FBA00C7EF11E9942E47049E149395","previous_id":null,"previous_guid":null,"modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"931717787BC649F890B93287319ACBDE","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"F218F4CD489246D1A1301B227BF3CBFF","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Prepare four wells of the cell line of interest by EDTA split (Basic Protocol 1). <\/div><\/div>"}},{"id":1054725,"guid":"C02CE4A7797346E087273C4A0003CA82","order_id":2,"type_id":26,"title":"notes","source":{"id":0,"parent_id":0,"uri":"","title":"","body":"<div class = \"text-blocks\"><div class = \"text-block\">For at least the first time performing this protocol, include positive and negative control cells in order to compare with cells of interest.<\/div><\/div>","created_on":0,"changed_on":0,"creator":{"name":" ","affiliation":"","affiliations":[],"username":"","link":null,"image":{"source":"","placeholder":""},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"comments":[]}}],"cases":[],"data":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":803860,"guid":"3E11DCE0C7EF11E9942E47049E149395","previous_id":803859,"previous_guid":"3E0FBA00C7EF11E9942E47049E149395","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"0EF308C95D044515AE5679941C014BEF","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"F71BD98BE28F4582BCD355B2B32C92A7","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">1 to 2 days after plating, follow <\/div><div class = \"text-block\"><a href=\"https:\/\/www.protocols.io\/view\/lipid-mediated-transfection-of-ipscs-basic-protoco-5deg23e\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">Basic Protocol 2<\/span><\/a><\/div><div class = \"text-block\"> (steps 6 to 9) for two of the wells in order to transfect with the pBI-MCS-EGFP plasmid.<\/div><\/div>"}}],"cases":[],"data":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":803861,"guid":"3E131560C7EF11E9942E47049E149395","previous_id":803867,"previous_guid":"8CD85610C7EF11E9942E47049E149395","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"DC632A20EDC449E890A06C337CBB7064","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"01FD9D5EF7F44DB7B9A7A6194DC947BC","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">One day later, aspirate medium and replace with fresh E8. In one trans- fected well and one un-transfected well, supplement medium with 2 \u03bcg\/ml doxycycline.<\/div><\/div>"}},{"id":1054725,"guid":"1082B87D6859485AA6748001DF573AAC","order_id":2,"type_id":26,"title":"notes","source":{"id":0,"parent_id":0,"uri":"","title":"","body":"<div class = \"text-blocks\"><div class = \"text-block\">If cells are more than 30% confluent when transfected, doxycycline may be added at the time of transfection in order to permit imaging the next day.<\/div><\/div>","created_on":0,"changed_on":0,"creator":{"name":" ","affiliation":"","affiliations":[],"username":"","link":null,"image":{"source":"","placeholder":""},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"comments":[]}}],"cases":[],"data":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":803862,"guid":"3E1426D0C7EF11E9942E47049E149395","previous_id":803861,"previous_guid":"3E131560C7EF11E9942E47049E149395","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"052AB95EEA3E44A8A96854A354BEBB93","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"BB0D8A8918024C29BB98C56613DCE348","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">One day later, aspirate medium, rinse twice with PBS, and image with a fluorescent microscope. <\/div><\/div>"}},{"id":1054725,"guid":"A2EAE912184E416D984F00AA822D72F4","order_id":2,"type_id":26,"title":"notes","source":{"id":0,"parent_id":0,"uri":"","title":"","body":"<div class = \"text-blocks\"><div class = \"text-block\">eGFP typically has a half-life of 24 hr, so fluorescence should persist for at least 2 to 3 days after doxycycline treatment.<\/div><\/div>","created_on":0,"changed_on":0,"creator":{"name":" ","affiliation":"","affiliations":[],"username":"","link":null,"image":{"source":"","placeholder":""},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"comments":[]}}],"cases":[],"data":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":803863,"guid":"3E15FB90C7EF11E9942E47049E149395","previous_id":803862,"previous_guid":"3E1426D0C7EF11E9942E47049E149395","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"870E60747285406D9F877821D6996259","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"F71618E1BB6A43859284FE62A3BCA9DF","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Since transfection is heterogeneous, only a subset of cells should express GFP. In addition, levels of expression may vary by the number of plasmid copies delivered to each cell. However, in cells with active tetracycline transactivator, the average intensity of GFP will be notably higher in the well exposed to doxycycline than in the well which was not. Some leaky expression is expected due to the sequence of the tetracycline operator in this plasmid, so un-transfected cells thus serve as a further negative control.<\/div><\/div>"}}],"cases":[],"data":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":803864,"guid":"57CB8E60C7EF11E9942E47049E149395","previous_id":803860,"previous_guid":"3E11DCE0C7EF11E9942E47049E149395","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"0D5DFC4A8EEB4EBFAC81E1B345799F6C","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"38C7A73D8489487B903FACC3B303077D","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">For each transfection, add <\/div><div class = \"text-block\"> of Opti-MEM and <\/div><div class = \"text-block\"> of total DNA to one 1.5-ml microcentrifuge tube and vortex for <\/div><div class = \"text-block\"> to <\/div><div class = \"text-block\">. In a second tube, combine <\/div><div class = \"text-block\"> of Opti-MEM and <\/div><div class = \"text-block\"> of Lipofectamine Stem reagent, and vortex for <\/div><div class = \"text-block\"> to <\/div><div class = \"text-block\">.<\/div><\/div>"}},{"id":1054725,"guid":"B6C415C0A4C411E9A5ABB3B7BC39A95C","order_id":2,"type_id":3,"title":"amount","source":{"amount":100,"unit":"\u00b5l","title":""}},{"id":1054726,"guid":"B97504F0A4C411E9A5ABB3B7BC39A95C","order_id":3,"type_id":3,"title":"amount","source":{"amount":3,"unit":"\u00b5g","title":""}},{"id":1054727,"guid":"270125D0A4C511E9A5ABB3B7BC39A95C","order_id":4,"type_id":4,"title":"duration","source":{"duration":2,"title":""}},{"id":1054728,"guid":"2AA77180A4C511E9A5ABB3B7BC39A95C","order_id":5,"type_id":4,"title":"duration","source":{"duration":3,"title":""}},{"id":1054729,"guid":"2DA918C0A4C511E9A5ABB3B7BC39A95C","order_id":6,"type_id":3,"title":"amount","source":{"amount":100,"unit":"\u00b5l","title":""}},{"id":1054730,"guid":"2FDE6F50A4C511E9A5ABB3B7BC39A95C","order_id":7,"type_id":3,"title":"amount","source":{"amount":10,"unit":"\u00b5l","title":""}},{"id":1054731,"guid":"35C24EF0A4C511E9A5ABB3B7BC39A95C","order_id":8,"type_id":4,"title":"duration","source":{"duration":2,"title":""}},{"id":1054732,"guid":"3B088F00A4C511E9A5ABB3B7BC39A95C","order_id":9,"type_id":4,"title":"duration","source":{"duration":3,"title":""}},{"id":1054733,"guid":"D1EE09A55E7641C0A75A43FFF8EFF942","order_id":10,"type_id":26,"title":"notes","source":{"id":0,"parent_id":0,"uri":"","title":"","body":"<div class = \"text-blocks\"><div class = \"text-block\"><span>For TALEN-mediated insertion to the AAVS1 or CLYBL locus, such as for the hNGN2 (Addgene, <\/span><a href=\"https:\/\/www.addgene.org\/105840\/\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">cat. no. 105840<\/span><\/a><span>) and hNIL (Addgene. <\/span><a href=\"https:\/\/www.addgene.org\/105841\/\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">cat. no. 105841<\/span><\/a><span>) differentiation cassettes, use a 2:1:1 ratio of <\/span><a href=\"#\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\"> <\/span><\/a><span> donor construct with <\/span><a href=\"#\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\"> <\/span><\/a><span> of each of the site-specific TALENs. <\/span><\/div><div class = \"text-block\"><span>For AAVS1: <\/span><a href=\"#\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\"> <\/span><\/a><span> of pTALdNC-AAVS1_T2 (Addgene, <\/span><a href=\"https:\/\/www.addgene.org\/80496\/\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">cat. no. 80496<\/span><\/a><span>) and <\/span><a href=\"#\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\"> <\/span><\/a><span> of pTALdNC-AAVS1_T1 (Addgene, <\/span><a href=\"https:\/\/www.addgene.org\/80495\/\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">cat. no. 80495<\/span><\/a><span>) per transfection. <\/span><\/div><div class = \"text-block\"><span>For CLYBL: <\/span><a href=\"#\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\"> <\/span><\/a><span> of pZT-C13-R1 (Addgene, <\/span><a href=\"https:\/\/www.addgene.org\/62197\/\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">cat. no. 62197<\/span><\/a><span>) and <\/span><a href=\"#\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\"> <\/span><\/a><span> of pZT-C13-L1 (Addgene, <\/span><a href=\"https:\/\/www.addgene.org\/62196\/\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">cat. no. 62196<\/span><\/a><span>) per transfection.<\/span><\/div><\/div>","created_on":0,"changed_on":0,"creator":{"name":" ","affiliation":"","affiliations":[],"username":"","link":null,"image":{"source":"","placeholder":""},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"comments":[]}}],"cases":[],"data":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":803865,"guid":"82319730C7EF11E9942E47049E149395","previous_id":803864,"previous_guid":"57CB8E60C7EF11E9942E47049E149395","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"D6A10415318341B2A539A4E6EF143028","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"66BE6DFCC1F44753A788FF54AB20D5B7","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Combine the contents of the two tubes and vortex again for <\/div><div class = \"text-block\"> to <\/div><div class = \"text-block\">. Incubate this<\/div><div class = \"text-block\">mixture for <\/div><div class = \"text-block\"> at <\/div><div class = \"text-block\">.<\/div><\/div>"}},{"id":1054725,"guid":"7E3A66E0A4C511E9A5ABB3B7BC39A95C","order_id":2,"type_id":4,"title":"duration","source":{"duration":2,"title":""}},{"id":1054726,"guid":"B7BB0370A4C511E9A5ABB3B7BC39A95C","order_id":3,"type_id":4,"title":"duration","source":{"duration":3,"title":""}},{"id":1054727,"guid":"BB4F74D0A4C511E9A5ABB3B7BC39A95C","order_id":4,"type_id":4,"title":"duration","source":{"duration":600,"title":""}},{"id":1054728,"guid":"C1413720A4C511E9A5ABB3B7BC39A95C","order_id":5,"type_id":24,"title":"temperature","source":{"temperature":0,"unit":"Room temperature","title":""}}],"cases":[],"data":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":803866,"guid":"87985790C7EF11E9942E47049E149395","previous_id":803865,"previous_guid":"82319730C7EF11E9942E47049E149395","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"45AB021FCD484D79B1F4A1F50711A2C9","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"CDBBE964D20D4F6B858544E41048F418","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Retrieve the cells plated in steps 3 to 4, and, using a P200 pipet tip and repeat pipettor, add <\/div><div class = \"text-block\"><span> of the complete transfection solution from step 6 <\/span><span style = \"font-weight:bold;\">dropwise<\/span><span>, evenly across the surface of the well. Return the cells to the incubator overnight.<\/span><\/div><\/div>"}},{"id":1054725,"guid":"D0929250A4C511E9A5ABB3B7BC39A95C","order_id":2,"type_id":3,"title":"amount","source":{"amount":200,"unit":"\u00b5l","title":""}}],"cases":[],"data":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":803867,"guid":"8CD85610C7EF11E9942E47049E149395","previous_id":803866,"previous_guid":"87985790C7EF11E9942E47049E149395","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"A36392A7C7484B528B81CBC3D272BE4E","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"4F91974D67DB4C5D9D30FE5954B5D484","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"> after transfection, aspirate transfection medium and replace with fresh E8. <\/div><div class = \"text-block\">If applicable, evaluate transfection efficiency by fluorescence microscopy.<\/div><\/div>"}},{"id":1054725,"guid":"345DC460C51B11E9801EBD22F56EE318","order_id":2,"type_id":4,"title":"duration","source":{"duration":86400,"title":""}},{"id":1054726,"guid":"1D5328B5A7F0486B98428718E6C26A95","order_id":3,"type_id":26,"title":"notes","source":{"id":0,"parent_id":0,"uri":"","title":"","body":"<div class = \"text-blocks\"><div class = \"text-block\"><span>All cells transfected with the hNGN2 (Addgene, <\/span><a href=\"https:\/\/www.addgene.org\/105840\/\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">cat. no. 105840<\/span><\/a><span> or <\/span><a href=\"https:\/\/www.addgene.org\/110492\/\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">110492<\/span><\/a><span>) and hNIL constructs (Addgene, <\/span><a href=\"https:\/\/www.addgene.org\/105841\/\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">cat. no. 105841<\/span><\/a><span> or <\/span><a href=\"https:\/\/www.addgene.org\/105842\/\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">105842<\/span><\/a><span>) will transiently express mCherry for <\/span><span style = \"font-weight:bold;\">3 to 4 days<\/span><span>, while only those cells with transgene insertion will maintain <\/span><span style = \"font-weight:bold;\">stable expression<\/span><span> of mCherry for longer periods of time. <\/span><\/div><div class = \"text-block\"><span>See <\/span><a href=\"https:\/\/www.protocols.io\/view\/basic-protocol-3-selection-and-enrichment-of-trans-5fvg3n6\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">Basic Protocols 3<\/span><\/a><span> and <\/span><a href=\"https:\/\/www.protocols.io\/view\/basic-protocol-4-isolation-and-validation-of-clona-5f7g3rn\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">4<\/span><\/a><span> for options for enrichment and clonal isolation.<\/span><\/div><\/div>","created_on":0,"changed_on":0,"creator":{"name":" ","affiliation":"","affiliations":[],"username":"","link":null,"image":{"source":"","placeholder":""},"badges":[],"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"comments":[]}}],"cases":[],"data":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0}],"document":null,"materials":[],"description":null,"changed_on":1576695371}